The invention provides methods and compositions that promote sunless tanning in human skin using a MAPK path-way inhibitor, particularly, a MEK-inhibitor, which induces melanogenesis in epidermal melanocytes alone or in combination with a cAMP-elevating agent. The compositions are preferably administered topically to the skin.